KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases

Laurence H. Beck; Isabelle Ayoub; Dawn Caster; Michael J. Choi; Jason Cobb; Duvuru Geetha; Michelle N. Rheault; Shikha Wadhwani; Timothy Yau; William L. Whittier

doi:10.1053/j.ajkd.2023.02.003

KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases

Laurence H. Beck, Isabelle Ayoub, Dawn Caster, Michael J. Choi, Jason Cobb, Duvuru Geetha, Michelle N. Rheault, Shikha Wadhwani, Timothy Yau, William L. Whittier

Pediatrics - Nephrology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

The KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases represents the first update to this set of recommendations since the initial set of KDIGO guideline recommendations was published in 2012. The pace of growth in our molecular understanding of glomerular disease has quickened and a number of newer immunosuppressive and targeted therapies have been introduced since the original set of guideline recommendations, making such an update necessary. Despite these updates, many areas of controversy remain. In addition, further updates since the publication of KDIGO 2021 have occurred which this guideline does not encompass. With this commentary, the KDOQI work group has generated a chapter-by-chapter companion opinion article that provides commentary specific to the implementation of the KDIGO 2021 guideline in the United States.

Original language	English (US)
Pages (from-to)	121-175
Number of pages	55
Journal	American Journal of Kidney Diseases
Volume	82
Issue number	2
DOIs	https://doi.org/10.1053/j.ajkd.2023.02.003
State	Published - Aug 2023

Bibliographical note

Publisher Copyright:
© 2023 National Kidney Foundation, Inc.

Keywords

CPG
Commentary
Glomerular disease
Glomerulonephritis
KDIGO 2021
KDOQI Work Group
Nephrotic syndrome

PubMed: MeSH publication types

Journal Article
Practice Guideline

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1053/j.ajkd.2023.02.003

OpenUrl availability

Full text

Cite this

@article{ceea935428c041039c8c3e98edd37176,

title = "KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases",

abstract = "The KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases represents the first update to this set of recommendations since the initial set of KDIGO guideline recommendations was published in 2012. The pace of growth in our molecular understanding of glomerular disease has quickened and a number of newer immunosuppressive and targeted therapies have been introduced since the original set of guideline recommendations, making such an update necessary. Despite these updates, many areas of controversy remain. In addition, further updates since the publication of KDIGO 2021 have occurred which this guideline does not encompass. With this commentary, the KDOQI work group has generated a chapter-by-chapter companion opinion article that provides commentary specific to the implementation of the KDIGO 2021 guideline in the United States.",

keywords = "CPG, Commentary, Glomerular disease, Glomerulonephritis, KDIGO 2021, KDOQI Work Group, Nephrotic syndrome",

author = "Beck, {Laurence H.} and Isabelle Ayoub and Dawn Caster and Choi, {Michael J.} and Jason Cobb and Duvuru Geetha and Rheault, {Michelle N.} and Shikha Wadhwani and Timothy Yau and Whittier, {William L.}",

note = "Publisher Copyright: {\textcopyright} 2023 National Kidney Foundation, Inc.",

year = "2023",

month = aug,

doi = "10.1053/j.ajkd.2023.02.003",

language = "English (US)",

volume = "82",

pages = "121--175",

journal = "American Journal of Kidney Diseases",

issn = "0272-6386",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases

AU - Beck, Laurence H.

AU - Ayoub, Isabelle

AU - Caster, Dawn

AU - Choi, Michael J.

AU - Cobb, Jason

AU - Geetha, Duvuru

AU - Rheault, Michelle N.

AU - Wadhwani, Shikha

AU - Yau, Timothy

AU - Whittier, William L.

PY - 2023/8

Y1 - 2023/8

N2 - The KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases represents the first update to this set of recommendations since the initial set of KDIGO guideline recommendations was published in 2012. The pace of growth in our molecular understanding of glomerular disease has quickened and a number of newer immunosuppressive and targeted therapies have been introduced since the original set of guideline recommendations, making such an update necessary. Despite these updates, many areas of controversy remain. In addition, further updates since the publication of KDIGO 2021 have occurred which this guideline does not encompass. With this commentary, the KDOQI work group has generated a chapter-by-chapter companion opinion article that provides commentary specific to the implementation of the KDIGO 2021 guideline in the United States.

AB - The KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases represents the first update to this set of recommendations since the initial set of KDIGO guideline recommendations was published in 2012. The pace of growth in our molecular understanding of glomerular disease has quickened and a number of newer immunosuppressive and targeted therapies have been introduced since the original set of guideline recommendations, making such an update necessary. Despite these updates, many areas of controversy remain. In addition, further updates since the publication of KDIGO 2021 have occurred which this guideline does not encompass. With this commentary, the KDOQI work group has generated a chapter-by-chapter companion opinion article that provides commentary specific to the implementation of the KDIGO 2021 guideline in the United States.

KW - CPG

KW - Commentary

KW - Glomerular disease

KW - Glomerulonephritis

KW - KDIGO 2021

KW - KDOQI Work Group

KW - Nephrotic syndrome

UR - http://www.scopus.com/inward/record.url?scp=85166318854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85166318854&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2023.02.003

DO - 10.1053/j.ajkd.2023.02.003

M3 - Article

C2 - 37341661

AN - SCOPUS:85166318854

SN - 0272-6386

VL - 82

SP - 121

EP - 175

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

IS - 2

ER -

KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this